From: Real-world experience of angiotensin receptor/neprilysin inhibitor (ARNI) usage in Thailand: a single-center, retrospective analysis
ARNI
Standard treatment
p-value
Target dose achievement
48 (55.2%)
59 (59.0%)
0.830
Average dose (mg/day)
285.7
Enalapril (23.6)
–
Losartan (90.8)
Candesartan (22.7)
Valsartan (120)
Hydralazine/nitrate (95.3/31.8)